p53 expression predicts progression and poor survival in T1 bladder tumours

Area of Science:

• Oncology
• Urology
• Molecular Pathology

Background:

• Histological grade is the sole prognostic factor for T1 transitional cell carcinoma (TCC) of the bladder, but its accuracy for individual clinical decisions is limited.
• Evaluating novel biomarkers is crucial for improving prognostic accuracy in bladder cancer management.

Purpose of the Study:

• To assess the prognostic relevance of p53 protein expression in T1 TCC of the bladder.
• To determine if p53 expression can predict tumor progression and patient survival in this cohort.

Main Methods:

• A retrospective case-control study involving 207 patients with T1 TCC.
• Comparison of 40 tumors from patients who developed muscle-invasive disease with 40 matched control tumors.
• p53 immunostaining was performed on tumor samples using a monoclonal antibody.

Main Results:

• Histological grade was the only clinical parameter influencing tumor evolution.
• p53 expression showed a significant correlation with tumor progression (p<0.0001) with high specificity (93.5%).
• p53 expression was strongly associated with patient survival, with significantly lower survival rates in p53-positive cases (p<0.0001).

Conclusions:

• p53 protein expression is a significant prognostic indicator for both survival and progression in T1 bladder tumors.
• p53 expression can aid in the early identification of T1 bladder tumors with a poor prognosis.
• This finding supports the potential clinical utility of p53 as a biomarker in bladder cancer management.